For the quarter ending 2025-09-30, CLOV had $1,407K increase in cash & cash equivalents over the period. $11,411K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -24,377 | -11,852 |
| Depreciation and amortization expense | 406 | 860 |
| Stock-based compensation | 26,106 | 52,632 |
| Change in fair value of warrants and amortization of warrants | 0 | 19 |
| Accretion, net of amortization | -396 | -946 |
| Change in accrued interest earned | -379 | -347 |
| Net realized gains on investment securities | 188 | 437 |
| Loss on investment | 0 | 0 |
| Accrued retrospective premiums | 38,884 | -43,201 |
| Prepaid expenses | -2,785 | 2,078 |
| Other assets | 8,367 | 2,084 |
| Healthcare receivables | 11,048 | -4,646 |
| Unpaid claims | 797 | -16,736 |
| Accounts payable and accrued expenses | -1,013 | -613 |
| Accrued salaries and benefits | -8,013 | 6,094 |
| Other liabilities | -3,852 | 2,464 |
| Net cash provided by operating activities from continuing operations | 12,103 | -10,885 |
| Net cash used in operating activities from discontinued operations | 0 | 0 |
| Net cash provided by operating activities | 12,103 | -10,885 |
| Purchases of short-term investments, available-for-sale, and held-to-maturity securities | 39,127 | 59,864 |
| Proceeds from sales of short-term investments and available-for-sale securities | 34,394 | 79,313 |
| Proceeds from maturities of short-term investments and available-for-sale securities | 0 | 25,801 |
| Purchases of property and equipment | 692 | 754 |
| Net cash provided by investing activities | -5,425 | 44,496 |
| Issuance of common stock, net of early exercise liability | 305 | 363 |
| Issuance of common stock under employee stock purchase plan, net of stock issuance costs | 0 | 555 |
| Cash paid for shares withheld related to stock-based compensation | 5,575 | 22,127 |
| Repurchases of common stock | 1 | 18,297 |
| Net cash used in financing activities | -5,271 | -39,506 |
| Net (decrease) increase in cash and cash equivalents | 1,407 | -5,895 |
| Cash and cash equivalents at beginning of period | 194,543 | - |
| Cash and cash equivalents at end of period | 190,055 | - |
CLOVER HEALTH INVESTMENTS, CORP. DE (CLOV)
CLOVER HEALTH INVESTMENTS, CORP. DE (CLOV)